BR112013000903A2 - agente de revestimento para uma preparação sólida farmacêutica, formulação de filme farmacêutica, e, preparação sólida farmacêutica revestida - Google Patents

agente de revestimento para uma preparação sólida farmacêutica, formulação de filme farmacêutica, e, preparação sólida farmacêutica revestida

Info

Publication number
BR112013000903A2
BR112013000903A2 BR112013000903A BR112013000903A BR112013000903A2 BR 112013000903 A2 BR112013000903 A2 BR 112013000903A2 BR 112013000903 A BR112013000903 A BR 112013000903A BR 112013000903 A BR112013000903 A BR 112013000903A BR 112013000903 A2 BR112013000903 A2 BR 112013000903A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical
solid preparation
coating agent
pharmaceutical solid
preparation
Prior art date
Application number
BR112013000903A
Other languages
English (en)
Other versions
BR112013000903B1 (pt
Inventor
Ryoji Yoshii
Suguru Takaki
Yuki Fujisaki
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of BR112013000903A2 publication Critical patent/BR112013000903A2/pt
Publication of BR112013000903B1 publication Critical patent/BR112013000903B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

agente de revestimento par auma preparação sólida farmacêutica, formulação de filme farmacêutica, e, preparação sólida farmacêutica revestida. o propósito da presente invenção é o de prover um agente de revestimento, que confira propriedades de barreira contra gás superiores, equivalentes áquelas de uma folha de ptp, a uma preparação sólida farmacêutica não embalada, sem que as propriedades de desintegração da preparação sólida farmacêutica sejam afetadas. o agente de revestimento da presente invenção compreende polietileno glicol tendo um peso molecular de 950 a 25.000, e uma argila intumescente, e a razão de massa de polietileno glicol e da argila intumescente é de 2: 8 a 6:4.
BR112013000903A 2010-08-31 2011-08-31 agente de revestimento para uma preparação sólida farmacêutica, formulação de filme farmacêutica, e, preparação sólida farmacêutica revestida BR112013000903B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010194355 2010-08-31
PCT/JP2011/069692 WO2012029820A1 (ja) 2010-08-31 2011-08-31 医薬固形製剤用のコーティング剤、医薬用フィルム製剤及び被覆医薬固形製剤

Publications (2)

Publication Number Publication Date
BR112013000903A2 true BR112013000903A2 (pt) 2016-05-17
BR112013000903B1 BR112013000903B1 (pt) 2019-12-03

Family

ID=45772899

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013000903A BR112013000903B1 (pt) 2010-08-31 2011-08-31 agente de revestimento para uma preparação sólida farmacêutica, formulação de filme farmacêutica, e, preparação sólida farmacêutica revestida

Country Status (14)

Country Link
US (1) US9381248B2 (pt)
EP (1) EP2612681B1 (pt)
JP (1) JP5853699B2 (pt)
KR (1) KR101483476B1 (pt)
CN (1) CN103079596B (pt)
BR (1) BR112013000903B1 (pt)
CA (1) CA2803052C (pt)
ES (1) ES2715830T3 (pt)
HU (1) HUE041795T2 (pt)
MX (1) MX341726B (pt)
PL (1) PL2612681T3 (pt)
SI (1) SI2612681T1 (pt)
TW (1) TWI535463B (pt)
WO (1) WO2012029820A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5871984B2 (ja) * 2013-04-15 2016-03-01 株式会社三和化学研究所 オルメサルタンメドキソミルを含有する医薬組成物
JP5744340B2 (ja) * 2013-05-24 2015-07-08 持田製薬株式会社 フィルムコーティング用組成物
TWI658842B (zh) * 2014-03-31 2019-05-11 日商東麗股份有限公司 固體製劑用之被覆劑以及由其所形成之被膜及被覆固體製劑
JP7253178B2 (ja) * 2017-06-08 2023-04-06 株式会社三旺コーポレーション 水素発生素材含有組成物及びその製造方法
WO2024049155A1 (ko) * 2022-08-31 2024-03-07 (주)셀트리온 이중 냄새 차폐 약학 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2766209A (en) * 1954-05-21 1956-10-09 Pure Oil Co Clay thickened lubricants having water resistant characteristics
US3383237A (en) * 1964-01-29 1968-05-14 Richardson Merrell Inc Tablet coating
US4476271A (en) * 1981-05-07 1984-10-09 Dai Nippon Toryo Co., Ltd. Aqueous dispersion type thermosetting coating composition
FR2671970B1 (fr) 1991-01-30 1995-06-23 Wellcome Found Comprimes dispersables dans l'eau.
US5639561A (en) * 1994-09-15 1997-06-17 Drescher Geschaeftsdrucke Gmbh Single-layered paper product
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US6448323B1 (en) 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
ES2248291T3 (es) 2001-02-27 2006-03-16 ROHM GMBH & CO. KG Agente de recubrimiento y aglutinante para formulaciones de medicamento con estabilidad al almcenamiento mejorada.
US20080305173A1 (en) 2001-07-31 2008-12-11 Beuford Arlie Bogue Amorphous drug beads
CA2503380A1 (en) 2002-10-25 2004-05-06 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions containing venlafaxine
JP4680061B2 (ja) 2003-08-20 2011-05-11 塩野義製薬株式会社 新規コーティング組成物
JP2006188490A (ja) 2004-12-06 2006-07-20 Freunt Ind Co Ltd フィルムコーティング組成物、その皮膜および錠剤
CN101171006B (zh) 2005-05-20 2010-12-01 第一三共株式会社 薄膜包衣制剂
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US8282956B2 (en) 2006-06-13 2012-10-09 Nippon Shinyaku Co. Ltd. Coated tablet
DE102006027790A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Typ-2-Diabetes Kombinations-Wafer
DE102006027793A1 (de) 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer
CA2664380C (en) 2006-09-25 2016-08-23 Takeda Pharmaceutical Company Limited Medicinal package
CA2671728C (en) 2006-12-20 2015-05-26 Genpharm Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
WO2009099734A1 (en) 2008-02-05 2009-08-13 Merck & Co., Inc. Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
KR20090128918A (ko) 2008-06-11 2009-12-16 한국화학연구원 염산 알푸조신이 함유된 서방형 제제의 제조
TWI438012B (zh) * 2008-12-25 2014-05-21 Toray Industries 固態製劑用之塗覆劑及使用其之固態製劑
GB201014041D0 (en) 2010-08-23 2010-10-06 Biofilm Ltd Soluble film

Also Published As

Publication number Publication date
EP2612681B1 (en) 2019-01-30
WO2012029820A1 (ja) 2012-03-08
US9381248B2 (en) 2016-07-05
SI2612681T1 (sl) 2019-05-31
CN103079596B (zh) 2015-08-19
PL2612681T3 (pl) 2019-09-30
JP5853699B2 (ja) 2016-02-09
TWI535463B (zh) 2016-06-01
CN103079596A (zh) 2013-05-01
CA2803052A1 (en) 2012-03-08
ES2715830T3 (es) 2019-06-06
US20130156829A1 (en) 2013-06-20
EP2612681A1 (en) 2013-07-10
MX2013002195A (es) 2013-03-18
BR112013000903B1 (pt) 2019-12-03
JPWO2012029820A1 (ja) 2013-10-31
CA2803052C (en) 2014-10-28
EP2612681A4 (en) 2014-04-30
KR101483476B1 (ko) 2015-01-16
TW201212953A (en) 2012-04-01
KR20130020966A (ko) 2013-03-04
MX341726B (es) 2016-08-31
HUE041795T2 (hu) 2019-05-28

Similar Documents

Publication Publication Date Title
BR112013000903A2 (pt) agente de revestimento para uma preparação sólida farmacêutica, formulação de filme farmacêutica, e, preparação sólida farmacêutica revestida
BR112012027202A2 (pt) copolímero em bloco usado em unidades não tecidas.
BRPI0821616B8 (pt) composição micelar de copolímero de bloco anfifílico contendo taxano e método para preparação da mesma
BR112015002421A2 (pt) composição farmacêutica ou nutracêutica com características de liberação sustentada e com resistência contra a influência do etanol
UY31698A (es) Preparacion solida de desintegracion oral
TN2011000471A1 (en) Pharmaceutical composition presenting anti-inflammatory properties
BR112012010083B8 (pt) Composição farmacêutica tópica de liberação sustentada e uso relacionado
BR112012021099A2 (pt) composição de borracha de copolímero, produto reticulado de borracha, laminado, e, mangueira
BR112013004889A2 (pt) composição de proteção de superfície sem fluoropolímero
BR112013003581A2 (pt) formulação farmacêutica ou nutracêutica gastro resistente que compreende um ou mais sais do ácido algínico
BR112014003277A2 (pt) produto de polímero, compacto de polímero, compacto de polímero para uso médico, toner e composição de polímero
BR112014010291A2 (pt) composições de lipossoma combinacionais para terapia de câncer
BR112013004892A2 (pt) composição de proteção de superfície sem fluoropolímero
GT200700064A (es) Agonistas de ep2
BRPI0719395C1 (pt) tablete revestido de filme
BR112013033536A2 (pt) composição de resina formadora de folha de fósforo
BR112012026596A2 (pt) método para preparar composições farmacêuticas pretendidas para administração oral compreendendo um ou mais ingredientes ativos e as composições que compreendem as mesmas
BR112013004416A2 (pt) agente terapêutico para enfisema pulmonar
BR112015009871A2 (pt) composições farmacêuticas compreendendo hidromorfona e naloxona
BR112012024618A2 (pt) usos de inibidores de dgat1
BR112013020537A2 (pt) suspensão aquosa e pó de liberação prolongada que compreendem metilfenidato
BR112013025696A2 (pt) composição compreendendo cimento portland para utilização em vertebroplastia
BR112012017136A2 (pt) Composição farmacêutica compreendendo 3-beta- hidróxi-5-alfa-pregnan-20-ona com propriedades de armazenamento e solubidade aperfeiçoadas.
SV2011003827A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
BRPI0915119B8 (pt) uso de iota carragenano

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/08/2011, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/08/2011, OBSERVADAS AS CONDICOES LEGAIS